Watching TV for 3 hours daily may up diabetes risk in kids

Agencies
July 31, 2017

London, Jul 31: Parents, take note! Being glued to television or video games for more than three hours a day may put your children at increased risk of developing diabetes, a study warns.

Researchers found that both adiposity, which describes total body fat, and insulin resistance, which occurs when cells fail to respond to insulin, were affected by longer hours of watching television and using computers.

"Our findings suggest that reducing screen time may be beneficial in reducing type 2 diabetes risk factors, in both boys and girls, from an early age," said Claire Nightingale, research fellow at St George's, University of London in the UK.

Researchers based their findings on a sample of nearly 4,500 nine to 10-year-old pupils from 200 primary schools in London, Birmingham and Leicester.

The children were assessed for a series of metabolic and cardiovascular risk factors, including blood fats, insulin resistance, fasting blood glucose levels, blood pressure and body fat.

They were asked about their daily screen time to include TV, computers, and games consoles.

Complete information was obtained for 4,495 (2,337 girls and 2,158 boys) out of the 5,887 who took part in the study between 2004 and 2007; additional data on physical activity was also available for 2,031 of them.

Around a third of the children spent less than an hour of screen time a day, but 28 per cent of the children said they clocked up one to two hours; 13 per cent said their tally was two to three hours; and 18 per cent said they spent more than three hours looking at screens every day.

Trends emerged between screen time and ponderal index—an indicator of weight in relation to height, and skinfolds thickness and fat mass index—indicators of total body fat.

Researchers found that these levels were all higher in children reporting more than three hours of daily screen time than in those who said they spent an hour or less on it.

The team also noted that there was a strong trend between levels of screen time and higher levels of leptin, the hormone that controls appetite, and insulin resistance. The trends remained significant even after taking account of potentially influential factors, including physical activity levels, researchers said.

Previous studies in adults had indicated that spending a lot of time in front of a screen is linked to a heightened risk of weight gain and type 2 diabetes, but until now it has not been clear that children might also be at risk.

"It would be very difficult to carry out this research today as smartphones and tablets are so universal. Children today therefore spend even more time looking at a screen than when the original dataset was taken," Nightingale said. The study was published in the journal Archives of Disease in Childhood.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 4,2020

Washington D.C., Jan 3: A new study has found out that diet significantly affects the mental health and well being of an individual.

The study was published in the journal European Neuropsychopharmacology.

"We have found that there is increasing evidence of a link between a poor diet and the worsening of mood disorders, including anxiety and depression. However, many common beliefs about the health effects of certain foods are not supported by solid evidence," said the lead researcher, Professor Suzanne Dickson.

According to the researchers, the link between diet and mental health can be firmly established in certain cases like that of the ability of a ketogenic diet being helpful for children with epilepsy and the impact of vitamin B12 deficiency on poor memory, depression and fatigue.

"With individual conditions, we often found very mixed evidence. With ADHD for example, we can see an increase in the quantity of refined sugar in the diet seems to increase ADHD and hyperactivity, whereas eating more fresh fruit and vegetables seems to protect against these conditions," said Dickson

But there are comparatively few studies, and many of them don't last long enough to show long-term effects," added Dickson.

The study further concludes that some food items can be associated with treatment and the betterment of certain mental health conditions.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
April 14,2020

There is no evidence that the Bacille Calmette-Guerin (BCG) vaccine, which is primarily used against tuberculosis, protects people against infection with the novel coronavirus, the World Health Organization (WHO) said.

The WHO therefore didn't recommend BCG vaccination for the prevention of COVID-19 in the absence of evidence, according to its daily situation report on Monday, Xinhua news agency reported.

"There is experimental evidence from both animal and human studies that the BCG vaccine has non-specific effects on the immune system. These effects have not been well characterized and their clinical relevance remains unknown," WHO stated.

Two clinical trials addressing the question are underway, and WHO will evaluate the evidence when it is available, it noted.

BCG vaccination prevents severe forms of tuberculosis in children and diversion of local supplies may result in an increase of disease and deaths from the tuberculosis, it warned.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 4,2020

The World Health Organisation on Wednesday said that anti-malarial drug hydroxychloroquine (HCQ) will return to the solidarity trial for the potential treatment of coronavirus disease.

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said: "On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol. The Executive Group received this recommendation and endorsed continuation of all arms of the solidarity trial, including hydroxychloroquine."

The world health body had temporarily suspended the usage of HCQ from the solidarity trial for coronavirus treatment on May 25 soon after a study published in one of the most reliable medical journals, which had suggested that the drug could cause more fatalities among COVID-19 patients.

However, the WHO chief said that the decision was taken as a precaution while the safety data was reviewed.

Ghebreyesus also said that the Data Safety and Monitoring Committee will continue to closely monitor the safety of all therapeutics being tested in the solidarity trial.

"So far, more than 3,500 patients have been recruited in 35 countries. WHO is committed to accelerating the development of effective therapeutics, vaccines and diagnostics as part of our commitment to serving the world with science, solutions and solidarity," he said.

Soon after HCQ was suspended from the trial, the Indian government had said that the antimalarial drug has been known for its benefits for a long time and its usage will be continued on the frontline workers, including police and healthcare professionals, as prophylaxis. The government had also said that studies were being conducted and the drug would be included in the clinical trial also for the treatment of coronavirus disease.

US President Donald Trump also had strongly advocated the use of HCQ and called it a "game-changer". He went to the extent of saying that he had taken the medicine.

Launched by WHO and partners, solidarity trial is an international clinical trial to find an effective treatment for COVID-19, including drugs to slow the progression of the disease or improve survival. The trial, which enrols patients from different countries, "will compare four treatment options against standard of care to assess their relative effectiveness against COVID-19", said WHO. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.